Pegylated Liposomal Doxorubicin HCL (Caelyx) in combination with Sandostatin LAR as salvage therapy in patients with small-cell lung cancer. [electronic resource]
Producer: 20060914Description: 553-7 p. digitalISSN:- 0258-851X
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Carcinoma, Small Cell -- drug therapy
- Disease Progression
- Doxorubicin -- administration & dosage
- Drug Therapy, Combination
- Female
- Humans
- Indium Radioisotopes -- therapeutic use
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Metastasis -- drug therapy
- Octreotide -- administration & dosage
- Polyethylene Glycols -- administration & dosage
- Quality of Life
- Radiotherapy, Adjuvant
- Salvage Therapy
- Survival Rate
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.